Stalveo is used to treat Parkinson's disease. It contains a combination of three active ingredients: levodopa, carbidopa, and entacapone. Together, these ingredients work to increase the concentration of dopamine in the brain, the neurotransmitter responsible for controlling movement. This helps alleviate symptoms associated with the disease, such as tremors, muscle stiffness, slow movement, and balance disturbances. This allows patients to perform daily activities more normally.
Stalveo also features a comprehensive formula that prolongs the effect of the treatment and reduces fluctuations in drug response that may occur throughout the day, known as "off periods." With continued use under a physician's supervision, it can contribute to improved symptom control and an increased quality of life for patients. It is an effective and reliable treatment option that helps support motor and psychological stability in patients with Parkinson's disease.